Navigation Links
Cellular Dynamics Raises $30 Million to Expand Its Product Line of Human Stem Cells and Tissue Cells
Date:4/7/2011

MADISON, Wis., April 7, 2011 /PRNewswire/ -- Cellular Dynamics International, Inc. (CDI), the world's only industrial manufacturer of human induced pluripotent stem cells (iPSCs) and tissue cells, has closed on a $30 million private equity round. This recent Series B Preferred Stock financing was led by an entity affiliated with Tactics II Stem Cell Ventures, which along with its affiliates led CDI's prior capital raises. Other investors in this financing round include Sam Zell's Equity Group Investments LLC, Sixth Floor Investors LP and G Force Investments LLC. CDI has raised a total of $100 million since 2004.

This financing enables the company to launch new iCell® iPSC lines as well as iCell Endothelial Cells, iCell Neurons, and iCell Hepatocytes lines for biomedical and pharmaceutical drug development and safety research, as well as continue to increase production capacity for its iCell Cardiomyocytes. CDI also plans to continue to rapidly expand its commercial organization to meet the growing demand for these iPSC-based products.

CDI's market-leading production process, which is unique in the industry, can produce large quantities of human tissue cells while maintaining their purity, quality and consistency. The company's iCell Cardiomyocytes product line is the first commercial product based on stem cells grown from adult tissue using CDI's iPSC technology developed by founder James A. Thomson. CDI grows its fully pluripotent stem cell lines from adult human donor blood samples. The company's iPSC technology coaxes the blood cells to turn back their developmental clock and become iPSCs, which then can be directed to develop into any of the human body's 200+ cell types.

Thomson, CDI Chief Scientific Officer and recent winner of the prestigious Albany Medical Award and King Faisal Award, commented, "Human pluripotent stem cells offer a unique window into human health a
'/>"/>

SOURCE Cellular Dynamics International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Groups Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
2. Cellular Dynamics International and Roche Transition Early Access Collaboration into a Standard Supply Agreement Ahead of Schedule
3. Intra-Cellular Therapies and Takeda Enter into Worldwide Collaboration to Develop and Commercialize Compounds for Schizophrenia
4. SecuraTrac Reveals Revolutionary Safety Solution Based on GPS & Cellular Technology at CES 2011
5. Transposagen and Cellular Dynamics International Cross-License Technologies for Induced Pluripotent Stem Cells
6. Largest Acellular Dermal Allografts for Abdominal Wall Repair Now Available From MTF
7. Tengion Presents New Data Demonstrating Functional Regeneration in a Diabetic Chronic Kidney Failure Model at the International Society for Cellular Therapy
8. Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia
9. Cellular Dynamics Partners with iPS Academia Japan, Inc. to In-License Seminal iPS Cell Patent Portfolio
10. Intra-Cellular Therapies Announces the Results of a Phase I PET Study for ITI-007 for the Treatment of Schizophrenia and Other Psychiatric Disorders
11. Cellular Dynamics Announces Commercial Launch of iCell(TM) Cardiomyocytes for Drug Candidate Toxicity Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014 Decision Resources Group finds ... Memphis health system and hospital ... integration, with rivals Methodist Le Bonheur Healthcare and Baptist ... to coordinate patient care. In addition, a national contract ... most health plan enrollment in the Memphis ...
(Date:8/27/2014)... DALLAS , August 27, 2014 ... "Dental Equipment Market By Products (Dental Radiology, CAD/CAM, Dental Chairs, ... 2019" published by MarketsandMarkets, the global Dental Equipment Market ... from $5,416.3 million in 2014, growing at a ... Browse 95 market data tables and 61 ...
(Date:8/27/2014)... Aug. 27, 2014 By now, if you haven,t ... living on this planet. The awareness campaign has brought this ... helped to raise over $88.5 Million (and counting) for ALS. ... some companies are starting to as well. One ... Florida , who actually works with ALS sufferers and ...
Breaking Medicine Technology:Memphis-area Health Systems Turn Attention to Clinical Integration 2Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2
... 31, 2011 MultiCell Technologies, Inc. (OTC Bulletin Board: ... U.S. patent 7,935,528 by the United States Patent and Trademark ... liver stem cells to treat liver disease.  Under the terms ... is the worldwide exclusive licensee of U.S. patent 7,935,528.   ...
... Biotech Ltd. (NASDAQ: SVA ), a leading provider ... Mr. Kenneth Lee as a director to the Board of ... Xianping Wang who resigned from the Board due to personal ... SAIF Partners, a leading growth capital fund focused on China ...
Cached Medicine Technology:MultiCell Technologies is Granted Stem Cell Patent 2MultiCell Technologies is Granted Stem Cell Patent 3Sinovac Appoints Kenneth Lee to Board of Directors 2
(Date:8/27/2014)... (PRWEB) August 27, 2014 Beginning in September, ... Olympic Games (DOG) as an interactive, fun way for ... be free to all K9 Dog Park Doggy Daycare clients ... two days per week. Clients will be able to ... webcams. The dogs that compete in D.O.G. will win ...
(Date:8/27/2014)... one of the leading purveyors of real and synthetic hair wigs, ... all its products, for the coming Labor Day. , People searching ... hair products in two ways: when they spend more than ... code LABOR10; while when they spend more than $299, they can ... coupon code is needed when securely checkout, there are about 50 ...
(Date:8/27/2014)... new UCLA study has shown this is definitely the case ... how to treat their prostate cancer. , UCLA researchers found ... a much more difficult time making treatment decisions, called decisional ... their care and their long-term outcomes. , The study should ... the findings to target men less likely to know a ...
(Date:8/27/2014)... Aug. 27, 2014 Stroke patients are 70 per ... medications one year later if they have a prescription ... at St. Michael,s Hospital and the Institute for Clinical ... centres, researchers determined how many Ontarians were taking their ... having a stroke. The results reveal the importance of ...
(Date:8/27/2014)... There is an ... case of pancreatic cancer, one of the most aggressive types ... patients die within five years after the diagnosis. The KIT ... mortality rate. For preclinical and clinical tests of the agents, ... from investors. This will allow for the further development of ...
Breaking Medicine News(10 mins):Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 2Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 3Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 4Health News:UniWigs Is Offering A Big Sale for Labor Day on All Its Products 2Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 2Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 3Health News:A prescription for better stroke care 2Health News:Preclinical development of tumor therapeutic agent starts 2
... integrate cardiovascular activity into their lives, such as walking, would ... the study researchers surveyed nearly 18,800 women, ages 70 to ... The data show women who walked for at least 1.5 ... than those who walked less than 40 minutes per week. ...
... chemotherapy improves survival and reduces the risk of recurrence in ... not spread beyond the ovary). ,About one quarter of ... when five-year survival is 85 percent. Most doctors may prefer ... 10 patients are adequately treated by surgery alone , thus ...
... be the healthiest environment for your child at bedtime. According ... may put children at risk for leukemia. Researchers have determined ... rhythm and suppress the production of melatonin. ,As an ... DNA from oxidative damage. Once damaged, DNA may mutate and ...
... says that Man's best friend might be able to detect ... can smell odors from malignant tumors in urine samples. ... over seven months to discriminate between urine from patients with ... was then given samples of urine from six control group ...
... Patients with diabetes, Crohn's disease, bowel cancer, constipation and ... medication orally instead of using injections.Scientists in India have ... deliver // drugs to manage diseases that often require ... ,The new gel can also prevent problems caused ...
... finds a cluster of risk factors known as metabolic ... of other risk factors. // ,Metabolic syndrome ... cardiovascular and coronary heart disease. Metabolic syndrome includes looking ... pressure.Metabolic syndrome has two different definitions including one by ...
Cached Medicine News:
... wide Mini-Sub cell GT system for ... acids in agarose gels includes a ... electrodes, a 15 x 7 cm ... two casting gates, and two 1.5 ...
... your data for future generations. Most gels can ... backing plate of our gel dryer, covering them ... over them to hold the cellophane flat. Tut's ... with an open area somewhat larger than the ...
... data for future generations. Most gels can be ... plate of our gel dryer, covering them with ... them to hold the cellophane flat. Tut's Tombs ... an open area somewhat larger than the gel ...
... Breeze Air Gel Dryer : Dry up to ... gels 8 10 cm without a vacuum ... drying, or no heat for controlled drying of ... dried gels. Add and remove gels at any ...
Medicine Products: